# US 2012/0083614 A1 · (20R,25S)-2-Methylene-19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 in Crystalline Form

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083614 A1
- Document ID: US20120083614A1
- Status: Published application
- Kind: A1
- Application number: 13/247,600
- Filed: 2011-09-28
- Published: 2012-04-05
- Earliest claimed: 2010-09-30
- Assignees: Wisconsin Alumni Research Foundation
- Inventors: Hector F. DeLuca; Pawel Grzywacz; James B. Thoden; Hazel Holden
- Web page: https://patentgrep.com/patent/US20120083614A1

## CPC

- C07C 401/00: Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07C 2601/14: The ring being saturated
- C07C 2602/24: the ring system containing nine carbon atoms, e.g. perhydroindane
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

A method of purifying (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 to obtain (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 in crystalline form. The method includes the steps of preparing a solvent of methanol and water, dissolving a product containing (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 to be purified in the solvent, cooling the solvent and dissolved product below ambient temperature for a sufficient amount of time to form a precipitate of (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 crystals, and recovering the (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 crystals.

## Claims

### Claim 1

(20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 in crystalline form.

### Claim 2

The crystalline form of (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 having molecular packing arrangement defined by space group P1 and unit cell dimensions a=6.4 Å, b=12.6 Å, c=16.0 Å, α=110.9°, β=95.3° and γ=90.6°.

### Claim 3 (depends on 2)

A three dimensional structure for (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 as defined by the molecular packing arrangement set forth in claim 2.

### Claim 4

A method of purifying (20R,25S)-2-methylene-19,26-dinor, 1α,25-dihydroxyvitamin D3, comprising the steps of:
(a) preparing a solvent comprising water and methanol;
(b) dissolving a product containing (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 to be purified in said solvent;
(c) cooling said solvent and dissolved product below ambient temperature for a sufficient amount of time to form a precipitate of (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 crystals; and
(d) separating the (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 crystals from the solvent.

### Claim 5 (depends on 4)

The method of claim 4 including the further step of maintaining said solvent and dissolved product at ambient temperature for a period of time prior to cooling below ambient temperature.

### Claim 6 (depends on 4)

The method of claim 4 wherein said solvent comprises 20% water and 80% methanol, by volume.

### Claim 7 (depends on 4)

The method of claim 4 wherein said solvent and dissolved product are cooled to about −20° C.

### Claim 8 (depends on 4)

The method of claim 4 wherein the step of separating comprises filtering the solvent and precipitate to obtain the crystals.

### Claim 9 (depends on 4)

The method of claim 4 including a further step (e) comprising repeating steps (a) through (d) using the recovered crystals from step (d) as the product of step (b).

### Claim 10 (depends on 7)

The method of claim 7 wherein said solvent and dissolved product are maintained at −20° C. for up to 7 weeks.

### Claim 11

A method of purifying (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3, comprising the steps of
(a) preparing a solvent comprising 80% methanol and 20% water, by volume;
(b) dissolving a product containing (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 to be purified in said solvent;
(c) cooling said solvent and dissolved product below ambient temperature for a sufficient amount of time to form a precipitate of (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 crystals; and
(d) recovering the (20R,25S)-2-methylene-19,26-dinor-1α,25-dihydroxyvitamin D3 crystals having a molecular packing arrangement defined by space group P1 and unit cell dimensions a=6.4 Å, b=12.6 Å c=16.0 Å, α=110.9°, β=95.3° and γ=90.6°, or any other space group that yields substantially the same crystalline packing arrangement.

### Claim 12 (depends on 11)

The method of claim 11 wherein said solvent and dissolved product is maintained at ambient temperature for a period of time prior to cooling below ambient temperature.

### Claim 13 (depends on 11)

The method of claim 11 wherein said solvent and dissolved product are cooled to about −20° C.

### Claim 14 (depends on 13)

The method of claim 13 wherein said solvent and dissolved product are maintained at about −20° C. for up to 7 weeks.

### Claim 15 (depends on 11)

The method of claim 11 wherein the step of recovering comprises filtering.

### Claim 16 (depends on 11)

The method of claim 11 further including the step of (e) repeating steps (a) through (d) using the recovered crystals from step (d) as the product of step (b).
